Attached files
| file | filename |
|---|---|
| 10-Q/A - SEPTEMBER 30, 2012 10-Q/A - PROLUNG INC | f10qa093012_10qz.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - PROLUNG INC | f10qa093012_ex32z1.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - PROLUNG INC | f10qa093012_ex31z1.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - PROLUNG INC | f10qa093012_ex31z2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PROLUNG INC | Financial_Report.xls |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Fresh Medical Laboratories, Inc..
/s/ Steven Eror | Date: November 26, 2012 |
Steven Eror | |
Acting Chief Financial Officer | |